tiprankstipranks
Trending News
More News >
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS

Apellis Pharmaceuticals (APLS) Revenue

Compare
999 Followers

Apellis Pharmaceuticals Revenue

Apellis Pharmaceuticals had a revenue of 199.91M in the quarter ending Dec 31, 2025, with -56.41%. This bring the company's revenue in the last twelve months to 1.00B, Increased -1.24%. In the fiscal year ending Dec 31, 2025, Apellis Pharmaceuticals had annual revenue of 1.00B with 28.46% growth.
Revenue (ttm)
1.00B
Revenue Growth
42.11%
P/S Ratio
2.56
Revenue/Employee
$1,423,804
Employees
705
Market Cap
$2.57B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
1.00B222.41M+28.46%
Dec 31, 2024
781.37M384.78M+97.02%
Dec 31, 2023
396.59M321.17M+425.83%
Dec 31, 2022
75.42M8.86M+13.31%
Dec 31, 2021
66.56M-184.08M-73.44%
Dec 31, 2020
250.65M+∞%
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017